Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,293 | 787 | 89.5% |
| Travel and Lodging | $1,170 | 4 | 10.2% |
| Education | $35.24 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $1,185 | 83 | $0 (2024) |
| INTUITIVE SURGICAL, INC. | $1,170 | 4 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,057 | 95 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,027 | 44 | $0 (2024) |
| Novo Nordisk Inc | $989.15 | 74 | $0 (2024) |
| PFIZER INC. | $854.91 | 100 | $0 (2024) |
| Amgen Inc. | $718.27 | 56 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $601.63 | 50 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $545.24 | 56 | $0 (2024) |
| Astellas Pharma US Inc | $481.37 | 31 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,249 | 132 | INTUITIVE SURGICAL, INC. ($1,170) |
| 2023 | $1,973 | 115 | Lilly USA, LLC ($398.29) |
| 2022 | $606.14 | 35 | Lilly USA, LLC ($103.02) |
| 2020 | $132.95 | 10 | GlaxoSmithKline, LLC. ($43.17) |
| 2019 | $1,645 | 135 | AstraZeneca Pharmaceuticals LP ($184.36) |
| 2018 | $2,002 | 191 | AstraZeneca Pharmaceuticals LP ($232.52) |
| 2017 | $1,890 | 178 | AstraZeneca Pharmaceuticals LP ($226.82) |
All Payment Transactions
796 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: OUD | ||||||
| 12/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/05/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Biological | ||||||
| 12/03/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $0.46 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: PAIN | ||||||
| 11/19/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Bone Health | ||||||
| 11/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Obesity | ||||||
| 11/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.86 | General |
| Category: NEUROSCIENCE | ||||||
| 11/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: PAIN | ||||||
| 10/31/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $29.06 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 10/30/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $231.86 | General |
| Category: SURGERY | ||||||
| 10/30/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $9.69 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: RESPIRATORY | ||||||
| 10/28/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: PAIN | ||||||
| 10/27/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $19.00 | General |
| Category: SURGERY | ||||||
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 47 | 4,672 | 13,015 | $896,931 | $541,450 |
| 2022 | 31 | 2,346 | 5,588 | $385,008 | $240,131 |
| 2021 | 22 | 1,428 | 4,795 | $303,470 | $178,424 |
| 2020 | 26 | 1,557 | 4,803 | $312,173 | $169,311 |
All Medicare Procedures & Services
126 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 555 | 1,040 | $167,420 | $84,321 | 50.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 41 | 3,840 | $95,355 | $70,018 | 73.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 363 | 1,519 | $113,925 | $67,412 | 59.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 515 | 515 | $77,250 | $63,167 | 81.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 509 | 1,007 | $112,200 | $55,220 | 49.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 262 | 978 | $53,790 | $33,920 | 63.1% |
| 99489 | Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 85 | 555 | $44,400 | $29,575 | 66.6% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 112 | 231 | $34,650 | $22,713 | 65.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 72 | 72 | $22,700 | $20,271 | 89.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 220 | 225 | $20,250 | $17,002 | 84.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 114 | 138 | $29,670 | $15,301 | 51.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 38 | 41 | $14,350 | $8,200 | 57.1% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 48 | 51 | $12,240 | $7,596 | 62.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 231 | 236 | $10,620 | $6,950 | 65.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 416 | 670 | $6,478 | $5,514 | 85.1% |
| 99484 | Care management services for behavioral health conditions, 20 minutes or more clinical staff time directed by health care professional | Office | 2023 | 52 | 154 | $8,470 | $4,629 | 54.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 25 | 25 | $4,375 | $3,938 | 90.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 52 | 82 | $10,120 | $3,695 | 36.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 19 | 19 | $3,230 | $2,822 | 87.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 74 | 74 | $3,330 | $2,179 | 65.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 97 | 97 | $1,940 | $1,691 | 87.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 29 | 34 | $3,910 | $1,602 | 41.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 39 | 40 | $2,570 | $1,566 | 60.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 19 | 19 | $3,610 | $1,338 | 37.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 54 | 132 | $5,280 | $1,255 | 23.8% |
About Dr. Thomas Wallace, MD
Dr. Thomas Wallace, MD is a Family Medicine healthcare provider based in Williamsport, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306882725.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Wallace, MD has received a total of $11,498 in payments from pharmaceutical and medical device companies, with $3,249 received in 2024. These payments were reported across 796 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($10,293).
As a Medicare-enrolled provider, Wallace has provided services to 10,003 Medicare beneficiaries, totaling 28,201 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 126 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Williamsport, PA
- Active Since 06/22/2006
- Last Updated 10/05/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1306882725
Products in Payments
- Da Vinci Surgical System (Device) $1,170
- MOUNJARO (Drug) $603.21
- FARXIGA (Drug) $483.34
- TRELEGY ELLIPTA (Drug) $469.88
- VRAYLAR (Drug) $455.86
- XARELTO (Drug) $417.26
- JARDIANCE (Drug) $374.54
- Ozempic (Drug) $315.53
- Rybelsus (Drug) $309.88
- CHANTIX (Drug) $271.78
- EVENITY (Biological) $268.96
- ENTRESTO (Drug) $265.18
- ELIQUIS (Drug) $261.97
- MYRBETRIQ (Drug) $254.93
- TRULICITY (Drug) $206.37
- BEVESPI AEROSPHERE (Drug) $185.42
- SHINGRIX (Biological) $175.35
- Veozah (Drug) $174.55
- Prolia (Biological) $169.51
- BREZTRI (Drug) $159.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Williamsport
Karen C Iccarelli, M.d, M.D
Family Medicine — Payments: $29,012
Frank Mazzotta, Do, DO
Family Medicine — Payments: $7,667
David Bresticker, Md, MD
Family Medicine — Payments: $6,326
Dr. Kenneth Durrwachter, Md, MD
Family Medicine — Payments: $4,982
Mona Chang, Md, MD
Family Medicine — Payments: $2,104
Jeniece Cooper, Md, MD
Family Medicine — Payments: $2,084